ME1 — Melodiol Global Health Cashflow Statement
0.000.00%
- AU$0.01m
- AU$8.96m
- AU$19.60m
Annual cashflow statement for Melodiol Global Health, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | -0.259 | 0 | 0 | -0.424 | -4.96 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -10.2 | -9.62 | -22.4 | -17.3 | -8.14 |
Capital Expenditures | -3.34 | -0.429 | -0.454 | -0.348 | -0.313 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | -0.403 | -0.917 | -1.94 | 0.232 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -3.34 | -0.832 | -1.37 | -2.28 | -0.081 |
Financing Cash Flow Items | -0.799 | -2.19 | 0 | -0.117 | 3.62 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 10 | 13.6 | 24.9 | 13.8 | 7.5 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -3.59 | 3.25 | 1.14 | -5.8 | -0.696 |